Kelvin Kesse is an associate in the firm’s Business Law Department and a member of the Life Sciences group. Mr. Kesse focuses his practice on securities, capital markets, SEC reporting, corporate governance and general corporate law. Mr. Kesse regularly advises clients on public and private securities offerings and has significant experience with U.S.-Canadian cross-border offerings and foreign private issuer offerings. Mr. Kesse handles IPOs and follow-on offerings, all aspects of corporate governance matters, SEC reporting requirements and compliance, stock exchange initial and additional listing and on-going listing requirements and compliance. He joined Goodwin in 2021.

Mr. Kesse is admitted to practice in the State of Washington, North Carolina and the District of Columbia only; his application to the Massachusetts bar is pending.

Areas of Practice
Domaines D’Expertise





Mr. Kesse’s representative transactions include:

  • Representing Cerevel Therapeutics in its $350 million follow-on public offering.

  • Representing EQRx in its $5.35 billion business combination with CM Life Sciences III.

  • Representing a commercial-stage biotech company in its $345 million initial public offering.*

  • Representing a health-focused technology company in its initial public offering.*

  • Representing a cancer screening and diagnostics company in its acquisition of a healthcare company for total consideration of up to $2.15 billion.*

  • Representing a provider of integrated information management solutions and services for the public sector in its $600 million offering of convertible senior notes.*

  • Representing a Canadian mining company in its acquisition of mines in the United States pursuant to a plan of arrangement for $460 million, and in a $100 million offering in connection therewith.*

  • Representing the selling shareholders in a $645.3 million follow-on equity offering, including $252.7 million in shares offered by such selling shareholders.*

  • Representing a Canadian-based gold producer in connection with an at-the-market offering of up to $100 million.*

  • Representing a life sciences company focused on biopsy diagnostics in its follow-on equity offering of $40 million.*

  • Serving as U.S. counsel for a Canadian mining company in connection with a $130 million private placement.*

  • Serving as U.S. counsel to a Chinese maker of infant milk formula in its $855 million global offering.*

  • Routinely representing various domestic companies and foreign private issuers with registration of securities under the ’33 Act, SEC reporting and/or matters arising in connection therewith, and general corporate governance.

  • Routinely representing various domestic companies and foreign private issuers with ’34 Act filings including Proxy Statements, Forms 10-K, 10-Q, 8-K, 20-F, 40-F and 6-K.

*Denotes experience prior to joining Goodwin.

Professional Experience

Prior to joining Goodwin, Mr. Kesse was an associate at K&L Gates LLP.

During law school, Mr. Kesse was the President of the Harvard African Law Association and served as a submissions editor for the Harvard Business Law Review.

Professional Activities
Mr. Kesse served as Past Secretary and Board Member of the Harvard Club of Seattle from 2015–2019.


Mr. Kesse was selected as a “Top 40 under 40” lawyer by National Black Lawyers in the State of Washington (2020–2021) and North Carolina (2021-2022).

In The News









J.D., 2015
Harvard Law School
B.A., 2012
University of Washington, Bothell
(magna cum laude)



North Carolina
District of Columbia
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique